Stocks That Hit 52-Week Lows On Tuesday
Tuesday's morning session saw 84 companies set new 52-week lows.
HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates First Wave BioPharma (NASDAQ:FWBI) with a Buy and maintains $18 price target.
First Wave Bio New Clinical Trial Study ‘Pilot Study To Assess Safety And Efficacy Of An Enteric Microgranule Formulation Of Adrulipase In Patients With Exocrine Pancreatic Insufficiency Due To Cystic Fibrosis.’
https://clinicaltrials.gov/ct2/show/NCT05719311
Brief Summary:
HC Wainwright & Co. Reiterates Buy on First Wave BioPharma, Maintains $18 Price Target
HC Wainwright & Co. analyst Yi Chen reiterates First Wave BioPharma (NASDAQ:FWBI) with a Buy and maintains $18 price target.
HC Wainwright & Co. Reiterates Buy on First Wave BioPharma
HC Wainwright & Co. analyst Yi Chen reiterates First Wave BioPharma (NASDAQ:FWBI) with a Buy.
Why Grom Social Enterprises Shares Are Trading Lower By 30%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares surged 85% to $2.2200. Sonoma Pharmaceuticals and EMC Pharma announced Department of Defense DAPA registration for Microcyn(R) Rx products.
12 Health Care Stocks Moving In Monday’s After-Market Session
Gainers Nymox Pharmaceutical (NASDAQ:NYMX) stock moved upwards by 20.7% to $0.52 during Monday’s after-market session. The market value…
First Wave BioPharma Provides Update On IND Filing For Phase 2 Trial Of Enhanced Microgranule Formulation Of Adrulipase For Exocrine Pancreatic Insufficiency
First Wave BioPharma, Inc. (NASDAQ:FWBI) ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies
First Wave BioPharma Announces Results Of Special Meeting Of Stockholders
First Wave BioPharma, Inc. (NASDAQ:FWBI) ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies
12 Health Care Stocks Moving In Thursday’s Intraday Session
Gainers Yield10 Bioscience (NASDAQ:YTEN) shares increased by 35.2% to $2.84 during Thursday’s regular session. Trading volume for Yield10…